Answers are grounded in this paper and cite their sources.
With external innovation becoming more and more important, many firms struggle with the question of how to balance their technology‐sourcing portfolio. This study addresses this issue by looking at the effects of portfolio diversity on performance outcomes and the conditions under which diversity is most likely to materialize. Using a dataset of strategic investments by pharmaceutical firms, the results show that the variance in relative technological proximity between the focal firm and its partners exhibits an inverted U‐shaped relationship with innovative performance and that this relationship is affected by the diversity of the external sourcing modes used in the portfolio.
No takes yet. Share an insight, caveat, or question.
Vareska van de Vrande (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: